This report studies the Keyhole Limpet Hemocyanin (KLH) market, KLH, which can be used as an active pharmaceutical ingredient (?API?), is a very large, high molecular weight, oxygen-carrying glycoprotein made of millions of atoms. There are two KLH subunit forms, KLH1 and KLH2, each composed of seven or eight functional units, with each functional unit having an oxygen binding site of two copper atoms. Keyhole limpet hemocyanin is an extremely large, heterogeneous glycosylated protein consisting of subunits with a molecular weight of 350,000 and 390,000 in aggregates with molecular weights of 4,500,000-13,000,000. Each domain of a KLH subunit contains two copper atoms that together bind a single oxygen molecule (O2). The KLH protein is potently immunogenic yet safe in humans and is therefore highly prized as a vaccine carrier protein.
KLH protein is derived only from the hemolymph of the giant keyhole limpet (megathura crenulata), which is native only to a limited stretch of the Pacific Ocean coastline along Southern California and Baja California, Mexico.
KLH can be used as an active pharmaceutical ingredient and has high medical value. Due to high technology barrier and scarce raw material, there are few companies able to produce KLH and biosyn highly monopolizes the market at the moment.
The global keyhole limpet hemocyanin production will increase to 2132g in 2017, from 1570g in 2012, it is estimated that the global keyhole limpet hemocyanin demand will develop with a CAGR of 4.03% in the coming five years.
Megathura crenulata is native to rocky coasts of Southern California, United States to Baja California, Mexico and are found at shallow depths below the low tide line. American companies dominate the keyhole limpet hemocyanin product market. But downstream demand of keyhole limpet hemocyanin mainly is concentrated in Europe. Owning to immature technology, there is no company in China produce KLH for the time being.
According to this study, over the next five years the Keyhole Limpet Hemocyanin (KLH) market will register a 2.0% CAGR in terms of revenue, the global market size will reach USD 10 million by 2024, from USD 9 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Keyhole Limpet Hemocyanin (KLH) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Keyhole Limpet Hemocyanin (KLH) market by product type, application, key manufacturers and key regions and countries.
This study considers the Keyhole Limpet Hemocyanin (KLH) value and volume generated from the sales of the following segments-
Segmentation by product type- breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
GMP/Clinic Grade
Research Grade
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Laboratory
Pharmaceuticals
This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
Biosyn
Sigma-Aldrich
Stellar Biotechnologies
Thermo Fisher Scientific
G-Biosciences
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Keyhole Limpet Hemocyanin (KLH) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Keyhole Limpet Hemocyanin (KLH) market by identifying its various subsegments.
Focuses on the key global Keyhole Limpet Hemocyanin (KLH) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Keyhole Limpet Hemocyanin (KLH) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Keyhole Limpet Hemocyanin (KLH) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
